Trial · NCT00093964
Results by group50
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 50
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Subjects With Progression-free Survival | Cilengitide 500 Milligrams (mg) | 7.5 | 95% Confidence Interval 1.6 to 20.4 | percentage of subjects | |
| Percentage of Subjects With Progression-free Survival | Cilengitide 2000 mg | 15.0 | 95% Confidence Interval 5.7 to 29.8 | percentage of subjects | |
| Percentage of Subjects With Overall Response Rate | Cilengitide 500 Milligrams (mg) | 5.0 | 95% Confidence Interval 0.6 to 16.9 | percentage of subjects | |
| Percentage of Subjects With Overall Response Rate | Cilengitide 2000 mg | 12.5 | 95% Confidence Interval 4.2 to 26.8 | percentage of subjects | |
| Time to Disease Progression | Cilengitide 500 Milligrams (mg) | 1.81 | Full Range 0.39 to 56.71 | months | |
| Time to Disease Progression | Cilengitide 2000 mg | 1.91 | Full Range 0.66 to 57.76 | months | |
| Overall Survival Time | Cilengitide 500 Milligrams (mg) | 6.54 | Full Range 1.45 to 65.92 | months | |
| Overall Survival Time | Cilengitide 2000 mg | 9.91 | Full Range 0.92 to 67.23 | months | |
| Percentage of Subjects With 1-year of Survival Rate | Cilengitide 500 Milligrams (mg) | 22.0 | 95% Confidence Interval 10.9 to 35.5 | percentage of subjects | |
| Percentage of Subjects With 1-year of Survival Rate | Cilengitide 2000 mg | 37.5 | 95% Confidence Interval 22.9 to 52.1 | percentage of subjects | |
| Maximum Observed Plasma Concentration (Cmax) | Cilengitide 500 Milligrams (mg) | Cycle 1 | 40.4 | Standard Deviation 24.4 | microgram per milliliter (mcg/mL) |
| Maximum Observed Plasma Concentration (Cmax) | Cilengitide 2000 mg | Cycle 1 | 105.7 | Standard Deviation 14.1 | microgram per milliliter (mcg/mL) |
| Maximum Observed Plasma Concentration (Cmax) | Cilengitide 500 Milligrams (mg) | Cycle 2 | 35.4 | Standard Deviation 20.6 | microgram per milliliter (mcg/mL) |
| Maximum Observed Plasma Concentration (Cmax) | Cilengitide 2000 mg | Cycle 2 | 169.7 | Standard Deviation 20.7 | microgram per milliliter (mcg/mL) |
| Time to Reach Maximum Plasma Concentration (Tmax) | Cilengitide 500 Milligrams (mg) | Cycle 1 | 1.13 | Full Range 1.08 to 1.17 | Hour (h) |
| Time to Reach Maximum Plasma Concentration (Tmax) | Cilengitide 2000 mg | Cycle 1 | 1.33 | Full Range 1.08 to 1.50 | Hour (h) |
| Time to Reach Maximum Plasma Concentration (Tmax) | Cilengitide 500 Milligrams (mg) | Cycle 2 | 1.17 | Full Range 1.08 to 1.25 | Hour (h) |
| Time to Reach Maximum Plasma Concentration (Tmax) | Cilengitide 2000 mg | Cycle 2 | 1.00 | Full Range 1.00 to 1.08 | Hour (h) |
| Area Under the Plasma Concentration-time Curve From Time Zero to Infinity After Administration (AUC 0-infinity) | Cilengitide 500 Milligrams (mg) | Cycle 1 | 92.7 | Standard Deviation 60.4 | Microgram per milliliter*hour (mcg/mL*h) |
| Area Under the Plasma Concentration-time Curve From Time Zero to Infinity After Administration (AUC 0-infinity) | Cilengitide 2000 mg | Cycle 1 | 346.5 | Standard Deviation 50.3 | Microgram per milliliter*hour (mcg/mL*h) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00093964/results